AdvaMedDX Members
AdvaMedDx members are medical technology firms that manufacture an in vitro diagnostic device or engage in research and development of such diagnostics.
Diagnostics
Learn more about our Diagnostics work.
AdvaMedDx Partners
AdvaMedDx collaborates with diagnostics associations across the country and around the world.
AdvaMedDx
AdvaMedDx promotes innovation and expanded access to quality testing.
AdvaMed Statement on Biden Administration Plan to Expand K-8 Testing
AdvaMed released a response to the Biden administration’s announcement today of its plan to expand COVID-19 testing in our nation’s K-8 schools.
AdvaMed Statement on Administration’s Expanded Investment in COVID Testing
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed)—the world’s largest trade association for medical technology and diagnostics companies in the world—released the following statement from President and CEO Scott Whitaker on…
AdvaMed Re-Launches Web-Based Platform to Assist Government with Potential Supply Shortfalls
AdvaMed unveiled a newly repurposed platform to help device manufacturers locate and partner with thousands of component part manufacturers and sellers, should they need them during the COVID pandemic.
AdvaMed Announces 200 Million Molecular COVID-19 Tests Shipped Nationwide
WASHINGTON, D.C. –New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million. A breakdown of the data shows that…
Weekly AdvaMed COVID-19 Testing Registry Update: Over 190 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 190 million. A breakdown of the data shows…
Weekly AdvaMed COVID-19 Testing Registry Update: Over 180 Million Molecular Tests Shipped Nationwide
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached over 180 million. A breakdown of the data shows…
First “ABC”—Flu A/B + COVID-19—Rapid Antigen Test Authorized by FDA
“Game-changing” testing innovation from Quidel will save lives heading into flu season WASHINGTON, D.C. – AdvaMed released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed…